世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

世界の医療用ガイドワイヤー市場調査レポート:2023年までの予測

Global Therapeutic Medical Guidewire Market Research Report - Forecast to 2023

 

出版社 出版年月電子版価格 ページ数
Market Research Future
マーケットリサーチフューチャー (MRFR)
2017年11月US$4,450
シングルユーザライセンス
153

サマリー

この調査レポートは世界の医療用ガイドワイヤー市場を分析・予測したMarket Research Futureの市場調査報告書です。

Description

Introduction
Guide wires are medical devices used in the surgical procedures such as interventional cardiology, interventional radiology, gastroenterology, vascular surgery, and many others. They are made up of stainless steel metallic structures, used to guide the catheter placement. The global therapeutic medical guide wire market is expecting a stable growth during the forecasted period, 2017-2023. The major driving factors for the growth of the market are growing prevalence of chronic disorders, growing preference towards minimally invasive surgical procedures, and technological advancements in the medical guide wire. However, lack of skilled physicians and guide wires associated problems can hamper the market growth in the coming future.

The global therapeutic medical guide wire market is expected to reach USD 3229.2 million by 2023 at a CAGR of 5.9% during the forecast period.
On the basis of type, the global therapeutic medical guide wire market is classified into solid guide wire and wrapped guide wire. Solid guide wire market is expected to command the largest market share of 62.7%, and this segment is also expected to grow at a fastest CAGR of 6.1% during the forecast period 2017 to 2023
On the basis of the application, the global therapeutic medical guide wire market is classified into peripheral artery disease, cardiovascular diseases, neurovascular diseases, and urological disease. The peripheral artery disease is expected to command the largest market share of 33.3% and this segment is also expected to grow at fastest CAGR of 6.2% during the forecast period.

Key Players
The leading market players in the global therapeutic medical guide wire market include Cordis (Cardinal Health), Biotronik, SP Medical A S, Infiniti Medical, Acme Monaco, Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Medical Corporation, Cook Medical, and others.

Study objectives
- To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global therapeutic medical guide wire market
- To provide insights into factors influencing and affecting the market growth
- To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
- To provide historical and forecast revenue of the market segments based on channels, applications, and regions for the global therapeutic medical guide wire market
- To provide strategic profiling of key players in the market and comprehensively analyze their market share, core competencies, and draw a competitive landscape for the market
- To provide economic factors that influence the global therapeutic medical guide wire market
- To provide detailed analysis of the value chain and supply chain of the global therapeutic medical guide wire market
Target Audience
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
- Key Executive (CEO and COO) and Strategy Growth Manager
Key Findings
- The Americas hold the largest share of the therapeutic medical guide wire market and is expected to reach USD 1108.0 million by 2023 at the fastest CAGR of 6.2%
- Cardiovascular disease market segment is the fastest growing segment with a CAGR of 6.1% in the global therapeutic medical guide wire market, by application
- Wrapped guide wire segment is contributing remarkable share in the market registering 62.7% in the global therapeutic medical guide wire market, by type in 2016

The report also covers regional analysis
- North America
o U.S.
o Canada
- Europe
o Germany
o France
o U.K
o Italy
o Spain
o Rest of Europe
- Asia Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific
- Middle East & Africa
o Middle East
o Africa



目次

Table of Contents

1 Report Prologue 13
2 Market Introduction 16
2.1 Research Objective 16
2.2 Assumptions & Limitations 17
2.2.1 Assumptions 17
2.2.2 Limitations 17
3 Research Methodology 18
3.1 Research Process 18
3.2 Primary Research 19
3.3 Secondary Research 19
3.4 Market Size Estimation 20
4 Market Dynamics 21
4.1 Introduction 21
4.2 Drivers 22
4.2.1 Growing Prevalence of chronic disorders (Impact weightage: 40%) 22
4.2.2 Growing preference towards minimally invasive surgical procedures (Impact weightage: 35%) 23
4.2.3 Technological Advancements in medical guidewire (Impact weightage: 25%) 24
4.3 Restrains 25
4.3.1 Lack of skilled physicians (impact weightage- 60%) 25
4.3.2 Guide wires associated problems (impact weightage- 40%) 26
4.4 Opportunities 27
4.4.1 Guide wire assisted surgery in elderly population 27
4.4.2 Macroeconomic Indicators 27
5 Market Factor Analysis 29
5.1 Porter’s Five Forces Model 29
5.1.1 Bargaining Power of Suppliers 30
5.1.2 Bargaining Power of Buyers 30
5.1.3 Threat of New Entrants 30
5.1.4 Threat of Substitutes 31
5.1.5 Intensity of Rivalry 31
5.2 Value Chain Analysis 31
5.2.1 Raw Material 32
5.2.2 Supplier 33
5.2.3 Manufacturer 34
5.2.4 Distributer 35
5.2.5 Customer 35
5.2.6 Consumer 36
5.3 Demand & Supply: Gap Analysis 37
5.4 Pricing Analysis 37
6 Global Therapeutic Medical Guidewire by Type 38
6.1 Introduction 38
6.2 Solid Guidewire 39
6.3 Wrapped guidewire 40
7 Global Therapeutic Medical guidewire by Shape 41
7.1 Introduction 41
7.2 J-Shape 42
7.3 Angled 43
7.4 Straight 43
8 Global Therapeutic Medical guidewire by Application 44
8.1 Introduction 44
8.2 Peripheral Artery Disease 45
8.3 Cardiovascular Diseases 46
8.4 Neurovascular Diseases 46
8.5 Urological Disease 47
9 Global Therapeutic Medical guidewire by End Users 48
9.1 Introduction 48
9.2 Hospitals 49
9.3 Clinics 50
9.4 Academic Institutes 50
10 Global Therapeutic Medical guidewire by Regions 51
10.1 Introduction 51
10.2 Americas 53
10.2.1 North America 55
10.2.1.1 US 57
10.2.1.2 Canada 58
10.2.2 South America 60
10.3 Europe 62
10.3.1 Western Europe 64
10.3.1.1 Germany 66
10.3.1.2 France 67
10.3.1.3 Italy 69
10.3.1.4 Spain 70
10.3.1.5 UK 72
10.3.1.6 Rest of Western Europe 73
10.3.2 Eastern Europe 75
10.4 Asia Pacific 77
10.4.1 China 79
10.4.2 India 81
10.4.3 Japan 82
10.4.4 South Korea 84
10.4.5 Australia 85
10.4.6 Rest of Asia Pacific 87
10.5 Middle East & Africa 89
10.5.1 UAE 92
10.5.2 Saudi Arabia 93
10.5.3 Oman 95
10.5.4 Kuwait 96
10.5.5 Qatar 98
10.5.6 Rest of Middle East & Africa 99
11 Competitive Landscape 101
11.1 Introduction 101
12 Company Profiles 102
12.1 Cordis (Cardinal Health) 102
12.1.1 Company Overview 102
12.1.2 Financials 102
12.1.3 Products 102
12.1.4 Strategy 102
12.1.5 Key Developments 102
12.2 Biotronik 103
12.2.1 Company Overview 103
12.2.2 Financials 103
12.2.3 Products 103
12.2.4 Strategy 103
12.2.5 Key Developments 103
12.3 SP Medical A S 104
12.3.1 Company Overview 104
12.3.2 Financials 104
12.3.3 Products 104
12.3.4 Strategy 104
12.3.5 Key Developments 104
12.4 Infiniti Medical 105
12.4.1 Company Overview 105
12.4.2 Financials 105
12.4.3 Products 105
12.4.4 Strategy 105
12.4.5 Key Developments 105
12.5 Acme Monaco 106
12.5.1 Company Overview 106
12.5.2 Financials 106
12.5.3 Products 106
12.5.4 Strategy 106
12.5.5 Key Developments 106
12.6 Abbott 107
12.6.1 Company Overview 107
12.6.2 Financials 107
12.6.3 Products 107
12.6.4 Strategy 107
12.6.5 Key Developments 107
12.7 Boston Scientific Corporation 108
12.7.1 Company Overview 108
12.7.2 Financials 108
12.7.3 Products 108
12.7.4 Strategy 108
12.7.5 Key Developments 108
12.8 Medtronic 109
12.8.1 Company Overview 109
12.8.2 Financials 109
12.8.3 Products 109
12.8.4 Strategy 109
12.8.5 Key Developments 109
12.9 Terumo Medical Corporation 110
12.9.1 Company Overview 110
12.9.2 Financials 110
12.9.3 Products 110
12.9.4 Strategy 110
12.9.5 Key Developments 110
12.10 Cook Medical 111
12.10.1 Company Overview 111
12.10.2 Financials 111
12.10.3 Products 111
12.10.4 Strategy 111
12.10.5 Key Developments 111
13 MRFR Conclusion 112
13.1 Key Findings 112
13.1.1 From CEO’s View Point 112
13.2 Key Companies to Watch 112
14 Appendix 113
14.1 Discussion Blue Print 113

List of Tables

TABLE 1 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY TYPE USD MILLION 2014-2023 38
TABLE 2 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR SOLID GUIDEWIRE USD MILLION 2014-2023 39
TABLE 3 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR WRAPPED GUIDEWIRE USD MILLION 2014-2023 40
TABLE 4 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPE USD MILLION 2014-2023 41
TABLE 5 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR J-SHAPE USD MILLION 2014-2023 42
TABLE 6 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR ANGLED USD MILLION 2014-2023 43
TABLE 7 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR STRAIGHT USD MILLION 2014-2023 43
TABLE 8 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATION USD MILLION 2014-2023 44
TABLE 9 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR PERIPHERAL ARTERY DISEASE USD MILLION 2014-2023 45
TABLE 10 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR CARDIOVASCULAR DISEASES USD MILLION 2014-2023 46
TABLE 11 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR NEUROVASCULAR DISEASES USD MILLION 2014-2023 46
TABLE 12 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR UROLOGICAL DISEASE USD MILLION 2014-2023 47
TABLE 13 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 48
TABLE 14 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR HOSPITALS USD MILLION 2014-2023 49
TABLE 15 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR CLINICS USD MILLION 2014-2023 50
TABLE 16 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE MARKET FOR ACADEMIC INSTITUTES USD MILLION 2014-2023 50
TABLE 17 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2014-2023 51
TABLE 18 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2014-2023 53
TABLE 19 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 54
TABLE 20 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 54
TABLE 21 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 54
TABLE 22 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 55
TABLE 23 NORTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 55
TABLE 24 NORTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 55
TABLE 25 NORTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 56
TABLE 26 NORTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 56
TABLE 27 US THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 57
TABLE 28 US THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 57
TABLE 29 US THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 57
TABLE 30 US THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 58
TABLE 31 CANADA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 58
TABLE 32 CANADA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 58
TABLE 33 CANADA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 59
TABLE 34 CANADA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 59
TABLE 35 SOUTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 60
TABLE 36 SOUTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 60
TABLE 37 SOUTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 61
TABLE 38 SOUTH AMERICA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 61
TABLE 39 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2014-2023 62
TABLE 40 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 63
TABLE 41 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 63
TABLE 42 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 63
TABLE 43 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 64
TABLE 44 WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 64
TABLE 45 WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 64
TABLE 46 WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 65
TABLE 47 WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 65
TABLE 48 GERMANY THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 66
TABLE 49 GERMANY THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 66
TABLE 50 GERMANY THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 66
TABLE 51 GERMANY THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 67
TABLE 52 FRANCE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 67
TABLE 53 FRANCE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 67
TABLE 54 FRANCE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 68
TABLE 55 FRANCE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 68
TABLE 56 ITALY THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 69
TABLE 57 ITALY THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 69
TABLE 58 ITALY THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 69
TABLE 59 ITALY THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 70
TABLE 60 SPAIN THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 70
TABLE 61 SPAIN THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 70
TABLE 62 SPAIN THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 71
TABLE 63 SPAIN THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 71
TABLE 64 UK THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 72
TABLE 65 UK THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 72
TABLE 66 UK THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 72
TABLE 67 UK THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 73
TABLE 68 REST OF WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 73
TABLE 69 REST OF WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 73
TABLE 70 REST OF WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 74
TABLE 71 REST OF WESTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 74
TABLE 72 EASTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 75
TABLE 73 EASTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 75
TABLE 74 EASTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 76
TABLE 75 EASTERN EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 76
TABLE 76 ASIA PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2014-2023 77
TABLE 77 ASIA PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 78
TABLE 78 ASIA PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 78
TABLE 79 ASIA PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 78
TABLE 80 ASIA PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 79
TABLE 81 CHINA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 79
TABLE 82 CHINA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 79
TABLE 83 CHINA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 80
TABLE 84 CHINA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 80
TABLE 85 INDIA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 81
TABLE 86 INDIA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 81
TABLE 87 INDIA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 81
TABLE 88 INDIA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 82
TABLE 89 JAPAN THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 82
TABLE 90 JAPAN THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 82
TABLE 91 JAPAN THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 83
TABLE 92 JAPAN THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 83
TABLE 93 SOUTH KOREA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 84
TABLE 94 SOUTH KOREA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 84
TABLE 95 SOUTH KOREA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 84
TABLE 96 SOUTH KOREA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 85
TABLE 97 AUSTRALIA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 85
TABLE 98 AUSTRALIA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 85
TABLE 99 AUSTRALIA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 86
TABLE 100 AUSTRALIA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 86
TABLE 101 REST OF ASIA PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 87
TABLE 102 REST OF ASIA PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 87
TABLE 103 REST OF ASIA PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 88
TABLE 104 REST OF ASIA PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 88
TABLE 105 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2014-2023 89
TABLE 106 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 90
TABLE 107 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 90
TABLE 108 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 91
TABLE 109 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 91
TABLE 110 UAE THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 92
TABLE 111 UAE THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 92
TABLE 112 UAE THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 92
TABLE 113 UAE THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 93
TABLE 114 SAUDI ARABIA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 93
TABLE 115 SAUDI ARABIA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 93
TABLE 116 SAUDI ARABIA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 94
TABLE 117 SAUDI ARABIA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 94
TABLE 118 OMAN THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 95
TABLE 119 OMAN THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 95
TABLE 120 OMAN THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 95
TABLE 121 OMAN THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 96
TABLE 122 KUWAIT THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 96
TABLE 123 KUWAIT THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 96
TABLE 124 KUWAIT THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 97
TABLE 125 KUWAIT THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 97
TABLE 126 QATAR THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 98
TABLE 127 QATAR THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 98
TABLE 128 QATAR THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 98
TABLE 129 QATAR THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 99
TABLE 130 REST OF MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY TYPES USD MILLION 2014-2023 99
TABLE 131 REST OF MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPES USD MILLION 2014-2023 99
TABLE 132 REST OF MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATIONS USD MILLION 2014-2023 100
TABLE 133 REST OF MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2014-2023 10

List of Figures


FIGURE 1 GLOBAL THERAPEUTIC MEDICAL GUIDE WIRE MARKET SHARE BY TYPE 2016 (%) 14
FIGURE 2 GLOBAL THERAPEUTIC MEDICAL GUIDE WIRE MARKET SHARE BY APPLICATION 2016 (%) 14
FIGURE 3 GLOBAL THERAPEUTIC MEDICAL GUIDE WIRE MARKET SHARE BY SHAPE 2016 (%) 15
FIGURE 4 MARKET STRUCTURE 17
FIGURE 5 RESEARCH PROCESS 18
FIGURE 6 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY TYPE USD MILLION 2016 & 2023 39
FIGURE 7 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY SHAPE USD MILLION 2016 -2023 42
FIGURE 8 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY APPLICATION USD MILLION 2016 & 2023 45
FIGURE 9 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY END USERS USD MILLION 2016 & 2023 49
FIGURE 10 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2016 & 2023 52
FIGURE 11 AMERICAS THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS MARKET SHARE 2016 (%) 53
FIGURE 12 EUROPE THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS MARKET SHARE 2016 (%) 62
FIGURE 13 ASIA PACIFIC THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS MARKET SHARE 2016 (%) 77
FIGURE 14 MIDDLE EAST & AFRICA THERAPEUTIC MEDICAL GUIDEWIRE BY REGIONS USD MILLION 2016 & 2023 89
FIGURE 15 GLOBAL THERAPEUTIC MEDICAL GUIDEWIRE COMPANY SHARE ANALYSIS 2016 (%) 101

 

ページTOPに戻る

あなたが最近チェックしたレポート一覧

  • 最近チェックしたレポートはありません。

お問合は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのお問合せはこちらのフォームから承ります

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

<無料>メルマガに登録する

 

 

ページTOPに戻る